We are live on
!
Find out more
CorMedix
CRMD
CRMD
92 hedge funds and large institutions have $66.2M invested in CorMedix in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
70% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 20
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
7% more funds holding
Funds holding: 86 → 92 (+6)
9.64% less ownership
Funds ownership: 42.28% → 32.64% (-9.6%)
13% less capital invested
Capital invested by funds: $76.1M → $66.2M (-$9.87M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less call options, than puts
Call options by funds: $447K | Put options by funds: $1.69M
Holders
92
Holders Change
+6
Holders Change %
+6.98%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
18
Increased
34
Reduced
20
Closed
12
Calls
$447K
Puts
$1.69M
Net Calls
-$1.25M
Net Calls Change
-$270K
Top Buyers
| 1 |
BlackRock
New York
|
+$1.73M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$911K |
| 3 |
Two Sigma Investments
New York
|
+$754K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$588K |
| 5 |
D.E. Shaw & Co
New York
|
+$537K |
Top Sellers
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$4.38M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.38M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.09M |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$991K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
-$595K |
